Business News

Business

Mastercard Surges Ahead with a 14% Revenue Jump to $7.3B in Q1, Fueled by Cross-Border Growth

Mastercard's Q1 revenue jumps 14% to $7.3B, driven by cross-border transactions. Net income rises 9% to $3.3B, with earnings per share at $3.59. Innovations and partnerships, inclu...

Business

Apple Faces Challenges in Q2 2025: Stock Slump, AI Delays, and Tariff Risks Loom

Apple prepares for its Q2 2025 earnings amid a stock slump, AI strategy delays, and geopolitical risks. Despite challenges, some segments show growth potential.

Business

Microsoft Announces Global Price Hike for Xbox Consoles and Games Amid Rising Costs

Microsoft has announced a global price increase for Xbox consoles, accessories, and some first-party games, citing rising development costs. The Xbox Series X and S see significant...

Business

Linde plc Holds Steady with $8.1 Billion Sales in Q1 2025 Amid Mixed Regional Performance

Linde plc reports steady Q1 2025 sales at $8.1 billion, with a rise in net income and earnings per share. Mixed regional performance noted, with growth in the Americas but declines...

Business

CVS Health Surpasses Expectations with a 7% Revenue Jump to $94.6B in Q1 2025

CVS Health Corporation announced a 7% increase in Q1 2025 revenue to $94.6B, with net income rising to $1.78B from $1.12B in 2024. The company revised its 2025 cash flow guidance t...

Business

GM Faces $5B Tariff Shock: Profit Outlook Slashed Amid Trade Policy Uncertainty

General Motors lowers its 2025 earnings forecast due to $5 billion exposure from US tariffs, with EBIT-adjusted profits now expected between $10 billion and $12.5 billion. CEO Mary...

Business

Eli Lilly's Q1 Revenue Soars 45% to $12.7 Billion Fueled by Mounjaro and Zepbound Success

Eli Lilly's first quarter revenue jumps 45% to $12.73 billion, driven by Mounjaro and Zepbound. Net income rises 23% to $2.76 billion, with EPS at $3.06. Plans for a $50 billion US...

Business

Biogen Announces Strong Q1 Growth with $2.4 Billion Revenue, Marking a 6% Increase

Biogen Inc. reports a 6% increase in Q1 revenue for 2025, totaling $2.4 billion, despite a dip in earnings per share. CEO Christopher Viehbacher emphasizes the company's strategic ...